-
Valeant Pharma Erases Thursday's Decline After Sale Of iNova Pharma
Friday, September 29, 2017 - 1:45pm | 100Read More...Valeant Pharma Inc. (NYSE: VRX) shares are trading higher by $0.73 at $14.49 in Friday's session. It has erased all of Thursday's decline of $0.63 and currently a dime over Wednesday's close of $14.39. The catalyst for the rebound is the announcement of the sale of iPharma. Investors...
-
Valeant Gets Closer To Left's $50 Target After New Accounting Fears
Monday, February 22, 2016 - 9:59pm | 379Read More...Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) shares plunged nearly 9 percent in Monday's after-hours trading session following word the company may have to restate financial results, before recovering slightly. The potential restatement, according to sources, would come on the heels of a...
-
Martin Shkreli Avoids Congressional Drug Price Hearings; Valeant Interim CEO Plans To Appear
Thursday, January 21, 2016 - 12:00pm | 210Read More...Former Turing Pharmaceuticals CEO Martin Shrkeli has refused to comply with a subpoena to testify in front of a Senate panel, which convenes next week to discuss drug prices, ArsTechnica reports. It's likely Shkreli also won't appear before a House committee investigation, given his...
-
Market Wrap For February 27: Yellen Talks Pushes Markets Higher
Thursday, February 27, 2014 - 5:47pm | 2887Read More...U.S. stocks rose after Federal Reserve boss Janet Yellen appeared in the hot-seat today speaking to the Committee on Financial Services and U.S. House of Representatives. Yellen said that it is too soon to determine the extent of which cold weather played a role in a recent batch of poor economic...
